loadpatents
name:-0.78217101097107
name:-0.12305402755737
name:-0.014341115951538
Wischik; Claude Michel Patent Filings

Wischik; Claude Michel

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wischik; Claude Michel.The latest application filed is for "adaptive neurological testing method".

Company Profile
12.50.50
  • Wischik; Claude Michel - Aberdeen GB
  • Wischik; Claude Michel - Aberdeenshire GB
  • Wischik; Claude Michel - Aberdeen Aberdeenshire GB
  • Wischik; Claude Michel - Old Aberdeen GB
  • Wischik; Claude Michel - Old Aberdeen Aberdeenshire N/A GB
  • Wischik; Claude Michel - Cambridge GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Adaptive Neurological Testing Method
App 20220172821 - Shiells; Helen Christine ;   et al.
2022-06-02
3, 7-diamino-10H-phenothiazine salts and their use
Grant 11,344,558 - Wischik , et al. May 31, 2
2022-05-31
3, 7-diamino-10h-phenothiazine Salts And Their Use
App 20220152038 - Wischik; Claude Michel ;   et al.
2022-05-19
Phenothiazine Diaminium Salts And Their Use
App 20220098161 - Marshall; Colin ;   et al.
2022-03-31
Administration And Dosage Of Diaminophenothiazines
App 20220008431 - Wischik; Claude Michel ;   et al.
2022-01-13
Phenothiazine diaminium salts and their use
Grant 11,180,464 - Marshall , et al. November 23, 2
2021-11-23
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20210322435 - Wischik; Claude Michel ;   et al.
2021-10-21
Medical methods utilising high purity diaminophenothiazinium compounds
Grant 11,116,772 - Storey , et al. September 14, 2
2021-09-14
Optimised Dosage Of Diaminophenothiazines In Populations
App 20210236509 - Wischik; Claude Michel ;   et al.
2021-08-05
Administration and dosage of diaminophenothiazines
Grant 11,065,256 - Wischik , et al. July 20, 2
2021-07-20
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 11,045,477 - Wischik , et al. June 29, 2
2021-06-29
Network Methods For Neurodegenerative Diseases
App 20210193322 - Wischik; Claude Michel ;   et al.
2021-06-24
Method and system for determining network connections
Grant 11,006,830 - Sommerlade , et al. May 18, 2
2021-05-18
Phenothiazine diaminium salts and their use
Grant 10,864,216 - Marshall , et al. December 15, 2
2020-12-15
Treatment of dementia
Grant 10,842,796 - Wischik , et al. November 24, 2
2020-11-24
Medical Methods Utilising High Purity Diaminophenothiazinium Compounds
App 20200268767 - Storey; John Mervyn David ;   et al.
2020-08-27
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20200261465 - Wischik; Claude Michel ;   et al.
2020-08-20
Phenothiazine Diaminium Salts And Their Use
App 20200246350 - Kind Code
2020-08-06
Medical methods utilising high purity diaminophenothiazinium compounds
Grant 10,537,578 - Storey , et al. Ja
2020-01-21
Administration And Dosage Of Diaminophenothiazines
App 20200016165 - Wischik; Claude Michel ;   et al.
2020-01-16
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 10,525,061 - Wischik , et al. J
2020-01-07
3,6-disubstituted xanthylium salts
Grant 10,399,955 - Clunas , et al. Sep
2019-09-03
Treatment Of Dementia
App 20190192530 - Wischik; Claude Michel ;   et al.
2019-06-27
Therapeutic Use Of Diaminophenothiazines
App 20190151329 - WISCHIK; Claude Michel ;   et al.
2019-05-23
Phenothiazine Diaminium Salts And Their Use
App 20190046537 - Marshall; Colin ;   et al.
2019-02-14
Therapeutic use of diaminophenothiazines
Grant 10,188,658 - Wischik , et al. Ja
2019-01-29
Method And System For Determining Network Connections
App 20190021594 - SOMMERLADE; Linda ;   et al.
2019-01-24
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20180263999 - WISCHIK; Claude Michel ;   et al.
2018-09-20
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 9,980,971 - Wischik , et al. May 29, 2
2018-05-29
Medical Methods Utilising High Purity Diaminophenothiazinium Compounds
App 20180078562 - STOREY; John Mervyn David ;   et al.
2018-03-22
Phenothiazine diaminium salts and their use
Grant 9,907,804 - Marshall , et al. March 6, 2
2018-03-06
Medical methods utilising high purity diaminophenothiazinium compounds
Grant 9,801,890 - Storey , et al. October 31, 2
2017-10-31
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20170273986 - WISCHIK; Claude Michel ;   et al.
2017-09-28
Methods of chemical synthesis and purification of diaminophenothiazinium compounds including methylthioninium chloride (MTC)
App 20170209456 - STOREY; John Mervyn David ;   et al.
2017-07-27
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 9,675,621 - Wischik , et al. June 13, 2
2017-06-13
3,6-disubstituted Xanthylium Salts
App 20170088534 - CLUNAS; Scott ;   et al.
2017-03-30
High purity diaminophenothiazinium compounds including methylthioninium chloride (MTC)
Grant 9,555,043 - Storey , et al. January 31, 2
2017-01-31
3,6-disubstituted xanthylium salts
Grant 9,549,933 - Clunas , et al. January 24, 2
2017-01-24
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20160296531 - WISCHIK; Claude Michel ;   et al.
2016-10-13
Phenothiazine Diaminium Salts And Their Use
App 20160237048 - MARSHALL; COLIN ;   et al.
2016-08-18
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 9,382,220 - Wischik , et al. July 5, 2
2016-07-05
Phenothiazine diaminium salts and their use
Grant 9,283,230 - Clunas , et al. March 15, 2
2016-03-15
3, 7-diamino-10h-phenothiazine Salts And Their Use
App 20160051559 - WISCHIK; Claude Michel ;   et al.
2016-02-25
Therapeutic Use Of Diaminophenothiazines
App 20160030444 - WISCHIK; Claude Michel ;   et al.
2016-02-04
High purity diaminophenothiazinium compounds including methylthioninium chloride (MTC)
Grant 9,242,946 - Storey , et al. January 26, 2
2016-01-26
Phenothiazine compounds for treating mild cognitive impairment
Grant 9,211,294 - Wischik , et al. December 15, 2
2015-12-15
3,7-diamino-10H-phenothiazine salts and their use
Grant 9,174,954 - Wischik , et al. November 3, 2
2015-11-03
Therapeutic use of diaminophenothiazines
Grant 9,149,481 - Wischik , et al. October 6, 2
2015-10-06
Ligands for aggregated tau molecules
Grant 8,895,313 - Kemp , et al. November 25, 2
2014-11-25
3,7-diamino-10h-phenothiazine Salts And Their Use
App 20140221359 - WISCHIK; Claude Michel ;   et al.
2014-08-07
3,6-disubstituted Xanthylium Salts
App 20140161731 - Clunas; Scott ;   et al.
2014-06-12
3,7-diamino-10H-phenothiazine salts and their use
Grant 8,710,051 - Wischik , et al. April 29, 2
2014-04-29
3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies
Grant 8,658,665 - Clunas , et al. February 25, 2
2014-02-25
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20130317012 - WISCHIK; Claude Michel ;   et al.
2013-11-28
Phenothiazine Diaminium Salts And Their Use
App 20130315992 - Clunas; Scott ;   et al.
2013-11-28
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 8,440,821 - Wischik , et al. May 14, 2
2013-05-14
Inhibition of tau-tau-association
Grant 8,278,298 - Wischik , et al. October 2, 2
2012-10-02
Inhibitors of protein aggregation
Grant 8,263,589 - Wischik , et al. September 11, 2
2012-09-11
Neurofibrillary labels
Grant 8,097,615 - Wischik , et al. January 17, 2
2012-01-17
3,6-disubstituted Xanthylium Salts
App 20110300074 - Clunas; Scott ;   et al.
2011-12-08
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20110294795 - WISCHIK; Claude Michel ;   et al.
2011-12-01
Methods of synthesis and/or purification of diaminophenothiazinium compounds
Grant 7,956,183 - Wischik , et al. June 7, 2
2011-06-07
3,7-diamino-10h-phinothiazine Salts And Their Use
App 20110118242 - WISCHIK; Claude Michel ;   et al.
2011-05-19
Materials and methods relating to protein aggregation in neurodegenerative disease
Grant 7,893,054 - Wischik , et al. February 22, 2
2011-02-22
3,7-diamino-10H-phenothiazine salts and their use
Grant 7,888,350 - Wischik , et al. February 15, 2
2011-02-15
Methods Of Chemical Synthesis And Purification Of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (mtc)
App 20110021510 - STOREY; John Mervyn David ;   et al.
2011-01-27
Therapeutic Use Of Diaminophenothiazines
App 20100290986 - Wischik; Claude Michel ;   et al.
2010-11-18
Materials and methods relating to protein aggregation in neurodegenerative disease
Grant 7,834,237 - Wischik , et al. November 16, 2
2010-11-16
Neurofibrillary labels
App 20100285605 - Wischik; Claude Michel ;   et al.
2010-11-11
Systems For Clinical Trials
App 20100280975 - Wischik; Claude Michel ;   et al.
2010-11-04
Phenothiazine Compounds For Treating Mild Cognitive Impairment
App 20100184752 - Wischik; Claude Michel ;   et al.
2010-07-22
Neurofibrillary labels
Grant 7,713,962 - Wischik , et al. May 11, 2
2010-05-11
Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
Grant 7,605,179 - Wischik , et al. October 20, 2
2009-10-20
Methods Of Synthesis And/or Purification Of Diaminophenothiazinium Compounds
App 20090259040 - Wischik; Claude Michel ;   et al.
2009-10-15
Inhibitors Of Protein Aggregation
App 20090209526 - Wischik; Claude Michel ;   et al.
2009-08-20
Inhibition of tau-tau association
Grant 7,534,786 - Wischik , et al. May 19, 2
2009-05-19
Materials and methods relating to protein aggregation in neurodegenerative disease
App 20090075984 - Wischik; Claude Michel ;   et al.
2009-03-19
3,7-diamino-10h-phenothiazine Salts And Their Use
App 20090054419 - Wischik; Claude Michel ;   et al.
2009-02-26
Neurofibrillary labels
App 20080219929 - Wischik; Claude Michel ;   et al.
2008-09-11
Methods of Chemical Synthesis and Purification of Diaminophenothiazinium Compounds Including Methylthioninium Chloride (Mtc)
App 20080207603 - Storey; John Mervyn David ;   et al.
2008-08-28
Materials and methods relating to protein aggregation in neurodegenerative disease
App 20080207604 - Wischik; Claude Michel ;   et al.
2008-08-28
Neurofibrillary labels
Grant 7,335,652 - Wischik , et al. February 26, 2
2008-02-26
Materials and methods relating to protein aggregation in neurodegenerative disease
Grant 7,335,505 - Wischik , et al. February 26, 2
2008-02-26
Inhibition of tau-tau-association
App 20070191352 - Wischik; Claude Michel ;   et al.
2007-08-16
Inhibition of tau-tau-association
App 20060014216 - Wischik; Claude Michel ;   et al.
2006-01-19
Inhibition of tau-tau association
Grant 6,953,794 - Wischik , et al. October 11, 2
2005-10-11
Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders
App 20050107472 - Wischik, Claude Michel ;   et al.
2005-05-19
Neurofibrillary labels
App 20040213736 - Wischik, Claude Michel ;   et al.
2004-10-28
Materials and methods relating to protein aggregation in neurodegenerative disease
App 20040110250 - Wischik, Claude Michel ;   et al.
2004-06-10
Inhibition of tau-tau-association
App 20020168687 - Wischik, Claude Michel ;   et al.
2002-11-14
Screening methods for agents that modulate or inhibit tau association with tau or map2
Grant 6,376,205 - Wischik , et al. April 23, 2
2002-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed